FDA Approved: DESVENLAFAXINE — Supplemental Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for desvenlafaxine submitted by Slate Run Pharmaceuticals, LLC, updating the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)